# Biocryst Pharmaceuticals Inc: Form DEF 14A, filed Apr 24, 2025

- Company: [Biocryst Pharmaceuticals Inc](/companies/bcrx.md) (CIK 882796)
- Form: DEF 14A
- Filed: 2025-04-24
- Accepted by EDGAR: Apr 24, 2025, 16:03 ET
- Period: 2025-06-12
- Accession: 0001628280-25-019659
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/882796/000162828025019659/bcrx-20250424.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/882796/000162828025019659/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/882796/000162828025019659/bcrx-20250424.htm

Filed Apr 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-019659. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.